2025 |
Settumba, S., Shahbazi, J., Byrne, M., Degenhardt, L., Grebely, J., Larance, B., . . . Farrell, M. (2025). Provider costs of treating opioid dependence with extended-release buprenorphine in Australia. Drug and Alcohol Review, 44(1), 179-194. DOI Europe PMC1 |
2025 |
Ibáñez-Martínez, N., Stevens, M. W. R., Civit-Bel, N., Moreno-Ferrer, N., Lopez-Ferré, S., Olivares-Casado, A., . . . Ali, R. (2025). Validity, reliability and clinical utility of ASSIST-Y in assessing risk of substance-related harm and dependence in Spanish male adolescents. Child and Adolescent Psychiatry and Mental Health, 19(1), 1-14. DOI |
2024 |
Ezard, N., Clifford, B., Siefried, K. J., Ali, R., Dunlop, A., McKetin, R., . . . Liu, Z. (2024). Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial. Addiction, 15 pages. DOI |
2024 |
Stevens, M. W. R., Cooper, M., Cusack, L., Ali, R. L., & Briley, A. L. (2024). Improving the quality of antenatal screening and early intervention for alcohol and other drug use: protocol for a multi-stage approach to systems reform. Addiction Science and Clinical Practice, 19(1), 2-1-2-8. DOI Scopus1 |
2024 |
Stevens, M. W. R., Cooper, M., Cusack, L., Ali, R. L., Holmwood, C., & Briley, A. L. (2024). Screening and early intervention for substance use during pregnancy: A retrospective case note review of antenatal care records. Drug and Alcohol Review, 43(7), 1817-1828. DOI |
2024 |
Farrell, M., Shahbazi, J., Chambers, M., Byrne, M., Gholami, J., Zahra, E., . . . CoLAB study team. (2024). 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial. International Journal on Drug Policy, 127, 104390-1-104390-11. DOI Scopus1 |
2023 |
Larney, S., Jones, N. R., Hickman, M., Nielsen, S., Ali, R., & Degenhardt, L. (2023). Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-2017. Addiction, 118(8), 13 pages. DOI Scopus3 Europe PMC3 |
2023 |
Bharat, C., Chidwick, K., Gisev, N., Farrell, M., Ali, R., & Degenhardt, L. (2023). Trends in use of medicines for opioid agonist treatment in Australia, 2013-2022. The International journal on drug policy, 123, 104255-1-104255-12. DOI Scopus3 |
2023 |
Stevens, M. W. R., Ivers, R., Telenta, J., & Ali, R. L. (2023). Building workforce capacity to address substance use in primary health care: preliminary results from a mixed-methods pilot program. Australian Journal of Primary Health, 30(1), 8 pages. DOI Scopus1 |
2022 |
Stoicescu, C., Lataire, Q., Peters, K., Amon, J. J., Kamarulzaman, A., Ali, R., . . . Cepeda, J. (2022). End compulsory drug treatment in the Asia-Pacific region. The Lancet, 399(10323), 419-421. DOI Scopus5 Europe PMC4 |
2022 |
Zahra, E., Chen, R., Nielsen, S., Tran, A. D., Santo, T., Degenhardt, L., . . . Larance, B. (2022). Examining the cost and impact of dosing fees among clients in opioid agonist treatment: results from a cross-sectional survey of Australian treatment clients. Drug and Alcohol Review, 41(4), 841-850. DOI Scopus9 WoS6 Europe PMC4 |
2022 |
Conigrave, J. H., Wilson, S., Conigrave, K. M., Chikritzhs, T., Hayman, N., Dawson, A., . . . Lee, K. S. K. (2022). ‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians. Addiction Science and Clinical Practice, 17(1), 1-11. DOI Scopus1 WoS1 Europe PMC1 |
2022 |
Jones, N. R., Hickman, M., Nielsen, S., Larney, S., Dobbins, T., Ali, R., & Degenhardt, L. (2022). The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: Findings from the OATS retrospective linkage study. Drug and Alcohol Dependence, 236, 109464-1-109464-9. DOI Scopus6 WoS5 Europe PMC3 |
2022 |
Ali, R., & Stevens, M. (2022). Moving toward Voluntary Community-Based Treatment for Drug Use and Dependence.. Health and human rights, 24(1), 183-187. Scopus2 Europe PMC1 |
2022 |
Stevens, M. W. R., Harland, J., Alfred, S., & Ali, R. L. (2022). Substance use in the emergency department: Screening for risky drug use, using the ASSIST-Lite. DRUG AND ALCOHOL REVIEW, 41(7), 1565-1576. DOI Scopus3 Europe PMC2 |
2022 |
Farrell, M., Shahbazi, J., Byrne, M., Grebely, J., Lintzeris, N., Chambers, M., . . . CoLAB study team. (2022). Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence. International Journal of Drug Policy, 100, 103492-1-103492-10. DOI Scopus27 WoS8 Europe PMC8 |
2021 |
Conigrave, K. M., Ali, R. L., Armstrong, R., Chikritzhs, T. N., d'Abbs, P., Harris, M. F., . . . Banks, E. (2021). Revision of the Australian guidelines to reduce health risks from drinking alcohol. Medical Journal of Australia, 215(11), 518-524. DOI Scopus14 WoS6 Europe PMC21 |
2021 |
Vuong, T., Ritter, A., Shanahan, M., Ali, R., Nguyen, N., & Minh, K. P. (2021). Quality of life as a predictor of time to heroin relapse among male residents following release from compulsory rehabilitation centres in Vietnam. Drug and Alcohol Review, 40(2), 296-306. DOI Scopus5 WoS3 Europe PMC2 |
2021 |
Nielsen, S., Sanfilippo, P., Belackova, V., Day, C., Silins, E., Lintzeris, N., . . . Larance, B. (2021). Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: Findings from a cross-sectional study in three Australian cities. Addiction, 116(6), 1482-1494. DOI Scopus4 WoS2 Europe PMC1 |
2021 |
Jones, N. R., Hickman, M., Larney, S., Nielsen, S., Ali, R., Murphy, T., . . . Degenhardt, L. (2021). Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001-2018: findings from the OATS retrospective cohort study. Drug and Alcohol Dependence, 218, 108354-1-108354-10. DOI Scopus9 WoS4 Europe PMC5 |
2021 |
Jones, N. R., Nielsen, S., Farrell, M., Ali, R., Gill, A., Larney, S., & Degenhardt, L. (2021). Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomes. Drug Alcohol Depend, 219, 1-8. DOI Scopus16 WoS10 Europe PMC4 |
2021 |
Bharat, C., Larney, S., Barbieri, S., Dobbins, T., Jones, N. R., Hickman, M., . . . Degenhardt, L. (2021). The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study. Addiction (Abingdon, England), 116(11), 3139-3152. DOI Scopus16 WoS11 Europe PMC5 |
2021 |
Siefried, K. J., Ezard, N., Christmass, M., Haber, P., Ali, R., & The Nccred Methamphetamine And Emerging Drugs Clinical Research Network Working Group. (2021). A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia.. Drug and alcohol review, 41(2), 11 pages. DOI Scopus7 WoS6 Europe PMC4 |
2020 |
Larney, S., Jones, N., Fiellin, D. A., Nielsen, S., Hickman, M., Dobbins, T., . . . Degenhardt, L. (2020). Data resource profile: the Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, Australia. International Journal of Epidemiology, 49(6), 1774-1775g. DOI Scopus11 WoS8 Europe PMC5 |
2020 |
Larance, B., Degenhardt, L., Grebely, J., Nielsen, S., Bruno, R., Dietze, P., . . . Farrell, M. (2020). Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia. Addiction, 115(7), 1295-1305. DOI Scopus50 WoS43 Europe PMC25 |
2020 |
Jin, H., Larney, S., Marshall, B. D. L., Degenhardt, L., Strang, J., Hickman, M., . . . Bruneau, J. (2020). Global opioid agonist treatment: a review of clinical practices by country. Addiction, 115(12), 2243-2254. DOI Scopus57 WoS38 Europe PMC26 |
2020 |
Larance, B., Byrne, M., Lintzeris, N., Nielsen, S., Grebely, J., Degenhardt, L., . . . CoLAB study team. (2020). Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study.. BMJ Open, 10(7), e034389. DOI Scopus12 WoS8 Europe PMC2 |
2020 |
McKetin, R., Boden, J. M., Foulds, J. A., Najman, J. M., Ali, R., Degenhardt, L., . . . Weatherburn, D. (2020). The contribution of methamphetamine use to crime: evidence from Australian longitudinal data. Drug and Alcohol Dependence, 216, 108262-1-108262-6. DOI Scopus19 WoS11 Europe PMC6 |
2019 |
Farrell, M., Martin, N. K., Stockings, E., Bórquez, A., Cepeda, J. A., Degenhardt, L., . . . McKetin, R. (2019). Responding to global stimulant use: challenges and opportunities. The Lancet, 394(10209), 1652-1667. DOI Scopus211 WoS132 Europe PMC100 |
2019 |
Marsden, J., Tai, B., Ali, R., Hu, L., Rush, A. J., & Volkow, N. (2019). Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?. Addiction, 114(8), 1346-1353. DOI Scopus50 WoS32 Europe PMC37 |
2019 |
Kalayasiri, R., Rungnirundorn, T., Ali, R., & Marsden, J. (2019). Regulation and decriminalisation of illegal substances in Thailand. Journal of Health Science and Medical Research, 37(2), 157-162. DOI Scopus3 |
2019 |
Marsden, J., Tai, B., Ali, R., Hu, L., Rush, A. J., & Volkow, N. D. (2019). Response to commentaries. Addiction, 114(8), 1357-1358. DOI |
2018 |
Ali, R., & Mcketin, R. (2018). Latent psychotic symptom profiles amongst people who use methamphetamine: what do they tell us about existing diagnostic categories?. Frontiers in Psychiatry, 9, 1-8. DOI Scopus10 WoS7 Europe PMC5 |
2018 |
Ezard, N., Dunlop, A., Hall, M., Ali, R., McKetin, R., Bruno, R., . . . Lintzeris, N. (2018). LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence. BMJ Open, 8(7), e020723. DOI Scopus14 WoS9 Europe PMC7 |
2018 |
Larney, S., Hickman, M., Fiellin, D. A., Dobbins, T., Nielsen, S., Jones, N. R., . . . Degenhardt, L. (2018). Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study. BMJ Open, 8(8), e025204-1-e025204-6. DOI Scopus21 WoS20 Europe PMC10 |
2018 |
Webster, S., Robinson, S., Ali, R., & Marsden, J. (2018). Improving outcomes in the treatment of opioid dependence (IOTOD): reflections on the impact of a medical education initiative on healthcare professionals' attitudes and clinical practice. Journal of European CME, 7(1), 1-8. DOI |
2018 |
Newcombe, D., Humeniuk, R., Dennington, V., & Ali, R. (2018). Participant perspectives on the Australian WHO ASSIST Phase III brief intervention for illicit drug use in a primary healthcare setting. Australian Journal of Primary Health, 24(6), 518-523. DOI |
2018 |
Vuong, T., Ritter, A., Shanahan, M., Ali, R., Nguyen, N., Pham, K., . . . Le, G. (2018). Outcomes of compulsory detention compared to community-based voluntary methadone maintenance treatment in Vietnam. Journal of Substance Abuse Treatment, 87, 9-15. DOI Scopus21 WoS13 Europe PMC7 |
2018 |
Humeniuk, R., Newcombe, D., Dennington, V., & Ali, R. (2018). A randomised controlled trial of a brief intervention for illicit drug use linked to ASSIST screening in a primary healthcare setting: results from the Australian component of the World Health Organization Phase III ASSIST studies. Australian Journal of Primary Health, 24(2), 149-154. DOI Scopus8 WoS7 Europe PMC4 |
2018 |
Peacock, A., Leung, J., Larney, S., Colledge, S., Hickman, M., Rehm, J., . . . Degenhardt, L. (2018). Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction, 113(10), 1905-1926. DOI Scopus743 WoS515 Europe PMC388 |
2018 |
Lintzeris, N., Monds, L., Rivas, C., Leung, S., Dunlop, A., Newcombe, D., . . . Ali, R. (2018). Transferring Patients from Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines. Journal of Addiction Medicine, 12(3), 234-240. DOI Scopus29 WoS16 Europe PMC7 |
2018 |
Larance, B., Dobbins, T., Peacock, A., Ali, R., Bruno, R., Lintzeris, N., . . . Degenhardt, L. (2018). The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study. The Lancet Psychiatry, 5(2), 155-166. DOI Scopus30 WoS24 Europe PMC14 |
2017 |
Vuong, T., Ritter, A., Nguyen, N., & Ali, R. (2017). Strengthening advocacy efforts with empirical evidence: a case example of the conduct, uptake and utilisation of research in drug policy decision-making in Vietnam. International Journal of Drug Policy, 49, 41-47. DOI Scopus1 WoS1 Europe PMC1 |
2017 |
Gowing, L., Ali, R., & White, J. (2017). Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews, 2017(5), 55 pages. DOI Scopus36 WoS15 Europe PMC12 |
2017 |
Xiaolu, R., Wenwen, W., Ali, R., Xu, L., Hong, W., Min, Z., & Jiang, D. (2017). Feasibility of studying a brief intervention to help Chinese villagers with problem alcohol use after an earthquake. Alcohol and Alcoholism, 52(4), 472-476. DOI Scopus11 WoS8 Europe PMC5 |
2017 |
Gowing, L., Ali, R., White, J., & Mbewe, D. (2017). Buprenorphine for managing opioid withdrawal. Cochrane Database of Systematic Reviews, 2017(2), 1-95. DOI Scopus122 WoS86 Europe PMC50 |
2017 |
Vuong, T., Nguyen, N., Le, G., Shanahan, M., Ali, R., & Ritter, A. (2017). The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast Asia. Harm Reduction Journal, 14(1), 2-1-2-14. DOI Scopus23 WoS16 Europe PMC7 |
2017 |
Schwartz, R., McNeely, J., Wu, L., Sharma, G., Wahle, A., Cushing, C., . . . Subramaniam, G. (2017). Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST. Journal of Substance Abuse Treatment, 76, 69-76. DOI Scopus17 WoS11 Europe PMC13 |
2016 |
Peacock, A., Bruno, R., Larance, B., Lintzeris, N., Nielsen, S., Ali, R., . . . Degenhardt, L. (2016). Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: a retrospective 7-day diary study. Drug and Alcohol Dependence, 166, 125-133. DOI Scopus12 WoS8 Europe PMC7 |
2016 |
Hotham, E. D., Ali, R. L., White, J. M., & Robinson, J. S. (2016). Ethical considerations when researching with pregnant substance users and implications for practice. Addictive Behaviors, 60, 242-243. DOI Scopus3 WoS2 Europe PMC1 |
2016 |
Vuong, T., Shanahan, M., Nguyen, N., Le, G., Ali, R., Pham, K., . . . Ritter, A. (2016). Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam. Drug and Alcohol Dependence, 168, 147-155. DOI Scopus29 WoS23 Europe PMC14 |
2016 |
McKetin, R., Gardner, J., Baker, A., Dawe, S., Ali, R., Voce, A., . . . Lubman, D. (2016). Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users. Psychiatry Research, 238, 166-171. DOI Scopus32 WoS27 Europe PMC15 |
2016 |
White, N., Ali, R., Larance, B., Zador, D., Mattick, R. P., & Degenhardt, L. (2016). The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film. Drug and Alcohol Review, 35(1), 76-82. DOI Scopus22 WoS20 Europe PMC7 |
2016 |
Hotham, E., Ali, R., & White, J. (2016). Analysis of qualitative data from the investigation study in pregnancy of the ASSIST Version 3.0 (the Alcohol, Smoking and Substance Involvement Screening Test). Midwifery, 34, 183-197. DOI Scopus10 WoS9 Europe PMC2 |
2016 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2016). Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews, 2016(5), 88 pages. DOI Scopus93 WoS101 Europe PMC34 |
2016 |
Larance, B., Mattick, R., Ali, R., Lintzeris, N., Jenkinson, R., White, N., . . . Degenhardt, L. (2016). Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia. Drug and Alcohol Review, 35(1), 83-91. DOI Scopus16 WoS12 Europe PMC4 |
2016 |
Harris, C., Ali, R., Perez-Downes, J., Baidoun, F., DeLima, M., Shah, J., . . . Makary, R. F. (2016). A Curious Case of Proximal Muscle Weakness with Eosinophilic Polymyositis.. Case reports in rheumatology, 2016, 7810916. DOI |
2016 |
Ali, R., Perez-Downes, J., Baidoun, F., Al Turk, B., Isache, C., Mohan, G., & Perniciaro, C. (2016). Challenges in Treating Secondary Syphilis Osteitis in an Immunocompromised Patient with a Penicillin Allergy: Case Report and Review of the Literature. CASE REPORTS IN INFECTIOUS DISEASES, 2016, 6 pages. DOI Europe PMC1 |
2015 |
Baidoun, F., Issa, R., Ali, R., & Al-Turk, B. (2015). Acute Unilateral Blindness from Superior Ophthalmic Vein Thrombosis: A Rare Presentation of Nephrotic Syndrome from Class IV Lupus Nephritis in the Absence of Antiphospholipid or Anticardiolipin Syndrome.. Case reports in hematology, 2015, 413975. DOI Europe PMC5 |
2015 |
Peacock, A., Degenhardt, L., Larance, B., Cama, E., Lintzeris, N., Ali, R., & Bruno, R. (2015). A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone. Pharmacoepidemiology and Drug Safety, 24(12), 1321-1333. DOI Scopus5 WoS4 |
2015 |
Larance, B., Lintzeris, N., Bruno, R., Peacock, A., Cama, E., Ali, R., . . . Degenhardt, L. (2015). The characteristics of a cohort who tamper with prescribed and diverted opioid medications. Journal of Substance Abuse Treatment, 58, 51-61. DOI Scopus21 WoS18 Europe PMC10 |
2015 |
Larance, B., Dietze, P., Ali, R., Lintzeris, N., White, N., Jenkinson, R., & Degenhardt, L. (2015). The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: uptake and issues arising from changing buprenorphine formulations. Drug and Alcohol Review, 34(6), 603-610. DOI Scopus7 WoS7 Europe PMC4 |
2015 |
Degenhardt, L., Larance, B., Bruno, R., Lintzeris, N., Ali, R., & Farrell, M. (2015). Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol. Addiction, 110(2), 226-237. DOI Scopus19 WoS18 Europe PMC10 |
2015 |
Peacock, A., Bruno, R., Cama, E., Kihas, I., Larance, B., Lintzeris, N., . . . Degenhardt, L. (2015). Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids. Drug and Alcohol Review, 34(6), 611-622. DOI Scopus12 WoS10 Europe PMC5 |
2015 |
White, N., Flaherty, I., Higgs, P., Larance, B., Nielsen, S., Degenhardt, L., . . . Lintzeris, N. (2015). Injecting buprenorphine-naloxone film: findings from an explorative qualitative study. Drug and Alcohol Review, 34(6), 623-629. DOI Scopus7 WoS6 Europe PMC5 |
2015 |
Gowing, L., Ali, R., Allsop, S., Marsden, J., Turf, E., West, R., & Witton, J. (2015). Global statistics on addictive behaviours: 2014 status report. Addiction, 110(6), 904-919. DOI Scopus301 WoS251 Europe PMC153 |
2015 |
Degenhardt, L., Bruno, R., Ali, R., Lintzeris, N., Farrell, M., & Larance, B. (2015). The introduction of a potentially abuse deterrent oxycodone formulation: early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study. Drug and Alcohol Dependence, 151(.), 56-67. DOI Scopus29 WoS29 Europe PMC18 |
2015 |
Tanguay, P., Kamarulzaman, A., Aramrattana, A., Wodak, A., Thomson, N., Ali, R., . . . Chabungbam, A. (2015). Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in Asia. Harm Reduction Journal, 12(1), 5 pages. DOI Scopus24 WoS24 Europe PMC13 |
2014 |
Larance, B., Carragher, N., Mattick, R., Lintzeris, N., Ali, R., & Degenhardt, L. (2014). A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses?. Drug and Alcohol Dependence, 142, 46-55. DOI Scopus13 WoS11 Europe PMC9 |
2014 |
Marsden, J., Eastwood, B., Ali, R., Burkinshaw, P., Chohan, G., Copello, A., . . . Day, E. (2014). Development of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT). Drug and Alcohol Dependence, 139, 121-131. DOI Scopus27 WoS21 Europe PMC11 |
2014 |
Larance, B., Lintzeris, N., Ali, R., Dietze, P., Mattick, R., Jenkinson, R., . . . Degenhardt, L. (2014). The diversion and injection of a buprenorphine-naloxone soluble film formulation. Drug and Alcohol Dependence, 136(1), 21-27. DOI Scopus46 WoS38 Europe PMC23 |
2014 |
Marshall, K., Gowing, L., Ali, R., & Le Foll, B. (2014). Pharmacotherapies for cannabis dependence. The Cochrane database of systematic reviews, 12(12), CD008940. DOI Scopus130 WoS73 Europe PMC30 |
2014 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2014). Alpha2-adrenergic agonists for the management of opioid withdrawal (review). The Cochrane database of systematic reviews, 2014(3), CD002024-1-CD002024-87. DOI Scopus81 WoS27 Europe PMC24 |
2014 |
Somogyi, A., Barratt, D., Ali, R., & Coller, J. (2014). Pharmacogenomics of methadone maintenance treatment. Pharmacogenomics, 15(7), 1007-1027. DOI Scopus40 WoS34 Europe PMC28 |
2014 |
Alho, H., Fischer, G., Torrens, M., Maremmani, I., Ali, R., & Clark, N. (2014). Guidelines in the treatment of opiate addiction: a review and recommendation. Heroin Addiction and Related Clinical Problems, 16(4), 33-39. Scopus3 WoS4 |
2013 |
Ali, R., Meena, S., Eastwood, B., Richards, I., & Marsden, J. (2013). Ultra-rapid screening for substance-use disorders: The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-Lite). Drug and Alcohol Dependence, 132(1-2), 352-361. DOI Scopus96 WoS73 Europe PMC63 |
2013 |
Hotham, E., Ali, R., White, J., Sullivan, T., & Robinson, J. (2013). Investigation of the Alcohol, Smoking, and Substance Involvement Screening Test (the ASSIST) Version 3.0 in pregnancy. Addictive Disorders & Their Treatment, 12(3), 123-135. DOI Scopus8 WoS5 |
2013 |
Amato, L., Davoli, M., Minozzi, S., Ferroni, E., Ali, R., & Ferri, M. (2013). Methadone at tapered doses for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, 2(2), 1-68. DOI Scopus69 WoS71 Europe PMC42 |
2013 |
McKetin, R., Lubman, D., Baker, A., Dawe, S., & Ali, R. (2013). Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA Psychiatry, 70(3), 319-324. DOI Scopus164 WoS142 Europe PMC89 |
2013 |
Lintzeris, N., Leung, S., Dunlop, A., Larance, B., White, N., Rivas, G., . . . Ali, R. (2013). A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence. Drug and Alcohol Dependence, 131(1-2), 119-126. DOI Scopus46 WoS38 Europe PMC24 |
2012 |
McKetin, R., Najman, J., Baker, A., Lubman, D., Dawe, S., Ali, R., . . . Mamun, A. (2012). Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES). Addiction, 107(11), 1998-2008. DOI Scopus112 WoS98 Europe PMC68 |
2012 |
Hotham, E., White, J., Ali, R., & Robinson, J. (2012). Screening for use of alcohol, tobacco and cannabis in pregnancy using self-report tools. Journal of Developmental Origins of Health and Disease, 3(4), 216-223. DOI Scopus1 |
2012 |
Vuong, T., Ali, R., Baldwin, S., & Mills, S. (2012). Drug policy in Vietnam: a decade of change?. International Journal of Drug Policy, 23(4), 319-326. DOI Scopus45 WoS39 Europe PMC24 |
2012 |
Humeniuk, R., Ali, R., Babor, T., Formigoni, M., Boerngen de Lacerda, R., Ling, W., . . . Vendetti, J. (2012). A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction, 107(5), 957-966. DOI Scopus170 WoS145 Europe PMC127 |
2012 |
Sarasvita, R., Tonkin, A., Utomo, B., & Ali, R. (2012). Predictive factors for treatment retention in methadone programs in Indonesia. Journal of Substance Abuse Treatment, 42(3), 239-246. DOI Scopus56 WoS51 Europe PMC44 |
2011 |
Amato, L., Davoli, M., Vecchi, S., Ali, R., Farrell, M., Faggiano, F., . . . Chengzheng, Z. (2011). Cochrane systematic reviews in the field of addiction: what's there and what should be. Drug and Alcohol Dependence, 113(2-3), 96-113. DOI Scopus19 WoS18 Europe PMC8 |
2011 |
Larance, B., Degenhardt, L., O'Brien, S., Lintzeris, N., Winstock, A., Mattick, R., . . . Ali, R. (2011). Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients. Drug and Alcohol Review, 30(6), 613-620. DOI Scopus20 WoS17 Europe PMC9 |
2011 |
Larance, B., Degenhardt, L., Lintzeris, N., Bell, J., Winstock, A., Dietze, P., . . . Horyniak, D. (2011). Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing. Drug and Alcohol Dependence, 118(2-3), 265-273. DOI Scopus65 WoS61 Europe PMC36 |
2011 |
Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2011). Oral substitution treatment of injecting opioid users for prevention of HIV infection (Review). The Cochrane Database of Systematic Reviews, (8), 004145-1-004145-116. DOI Scopus213 WoS214 Europe PMC108 |
2011 |
Srisurapanont, M., Arunpongpaisal, S., Wada, K., Marsden, J., Ali, R., & Kongsakon, R. (2011). Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis. Progress in Neuro-psychopharmacology & Biological Psychiatry, 35(4), 959-964. DOI Scopus80 WoS61 Europe PMC38 |
2011 |
Black, E., Larance, B., Mattick, R., Lintzeris, N., Degenhardt, L., Bruno, R., . . . Holland, R. (2011). MINIMISING THE UNINTENDED CONSEQUENCES OF OPIOID TREATMENT: DEVELOPMENT OF A DRUG BEHAVIOUR SCALE FOR USE IN AUSTRALIA. DRUG AND ALCOHOL REVIEW, 30, 11. |
2011 |
Marshall, K., Gowing, L., & Ali, R. (2011). Pharmacotherapies for cannabis withdrawal. Cochrane Database of Systematic Reviews, (1), 008940-1-008940-11. DOI |
2010 |
Ali, R., Marsden, J., Srisurapanont, M., Sunga, A., Baigent, M., & Monteiro, M. (2010). Methamphetamine psychosis in Australia, Philippines, and Thailand: Recommendations for acute care and clinical inpatient management. Addictive Disorders & Their Treatment, 9(4), 143-149. DOI Scopus12 WoS8 |
2010 |
Tomas-Rossello, J., Rawson, R., Zarza, M., Bellows, A., Busse, A., Saenz, E., . . . Ling, W. (2010). United Nations Office on Drugs and Crime International Network of Drug Dependence Treatment and Rehabilitation Resource Centres: Treatnet. Substance Abuse, 31(4), 251-263. DOI Scopus16 WoS11 Europe PMC9 |
2010 |
Kettler, L., Nikic, M., Newcombe, D., & Ali, R. (2010). Mood disturbance and withdrawal severity in substitution treatment for opioid dependence: Their association and impact on continued illicit drug use. Addictive Disorders & Their Treatment, 9(1), 1-7. DOI |
2010 |
Poznyak, V., Ali, R., Meena, S., & Du, J. (2010). Substance involvement screening test (assist) symposium. Drug and Alcohol Review, 29(Suppl 1), 59. |
2010 |
Hotham, E., Ali, R., White, J., & Robinson, J. (2010). The alcohol, smoking and substance involvement screening test (the assist) version 3.0 in pregnancy. Drug and Alcohol Review, 29(Suppl 1), 35. |
2010 |
Edson, M., Ali, R., & Buisman-Pijlman, F. (2010). Can recent advances in prevention and treatment of occupational blood-born enfections bring NSP in prisons a step closer. Drug and Alcohol Review, 29(Suppl 1), 25. |
2010 |
Gowing, L., Ali, R., & White, J. (2010). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. The Cochrane Database of Systematic Reviews, (1), 28 pages. DOI Scopus25 WoS4 |
2009 |
Gowing, L., Ali, R., & White, J. (2009). Opioid antagonists with minimal sedation for opioid withdrawal. The Cochrane Database of Systematic Reviews, 2009(4), 1-47. DOI Scopus29 WoS19 Europe PMC13 |
2009 |
Degenhardt, L., Larance, B., Bell, J., Winstock, A., Lintzeris, N., Ali, R., . . . Mattick, R. (2009). Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation. Medical Journal of Australia, 191(3), 161-165. DOI Scopus46 WoS43 Europe PMC21 |
2009 |
Gowing, L., Ali, R., & White, J. (2009). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, 2009(3), 1-76. DOI Scopus176 WoS69 Europe PMC38 |
2009 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2009). Alpha₂-adrenergic agonists for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, Online(2), 1-87. DOI Scopus102 WoS44 Europe PMC15 |
2009 |
Lintzeris, N., Ali, R., Dunlop, A., Haber, P., & Wodak, A. (2009). PRESCRIPTION OPIOID POLICY: WHAT IS WORKING, NOT WORKING, AND WHAT CAN WE DO BETTER. DRUG AND ALCOHOL REVIEW, 28, A75. |
2009 |
Gowing, L., Ali, R., & White, J. M. (2009). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (3), 38 pages. DOI Scopus31 WoS56 Europe PMC15 |
2009 |
Ali, R., Burrows, D., Gowing, L., Vial, R., Walsh, N., Onyancha, P., & Finnerty, E. (2009). Review of Global Policy Architecture and Country Level Practice on HIV/AIDS and Drug Treatment. |
2009 |
Mcketin, R., Ross, J., Najman, J., Baker, A., Lubman, D., Dawe, S., . . . Mamun, A. (2009). TREATMENT OUTCOMES FOR METHAMPHETAMINE USE: FINDING FROM THE METHAMPHETAMINE TREATMENT EVALUATION STUDY (MATES). DRUG AND ALCOHOL REVIEW, 28, A76-A77. |
2008 |
Humeniuk, R., Ali, R., Babor, T., Farrell, M., Formigoni, M., Jittiwutikarn, J., . . . Simon, S. (2008). Validation of the alcohol, smoking and substance involement screening test (ASSIST). Addiction, 103(6), 1039-1047. DOI Scopus807 WoS678 Europe PMC604 |
2008 |
Gibson, A., Degenhardt, L., Mattick, R., Ali, R., White, J., & O'Brien, S. (2008). Exposure to opioid maintenance treatment reduces long-term mortality. Addiction, 103(3), 462-468. DOI Scopus159 WoS145 Europe PMC98 |
2008 |
Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2008). Substitution treatment of injecting opioid users for prevention of HIV infection. The Cochrane Database of Systematic Reviews, 2009(2), 1-102. DOI Scopus234 WoS129 Europe PMC55 |
2008 |
Somogyi, A., Larsen, M., Abadi, R., Jittiwutikarn, J., Ali, R., & White, J. (2008). Flexible dosing of Tincture of Opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology, 66(5), 640-647. DOI Scopus18 WoS19 Europe PMC13 |
2008 |
Lawrinson, P., Ali, R., Buarvirat, A., Chiamwongpaet, S., Dvoryak, S., Habrat, B., . . . Zhao, C. (2008). Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction, 103(9), 1484-1492. DOI Scopus195 WoS176 Europe PMC140 |
2008 |
Hotham, E., Ali, R., White, J., & Robinson, J. (2008). Pregnancy-related changes in tobacco, alcohol and cannabis use reported by antenatal patients at two public hospitals in South Australia. Australian & New Zealand Journal of Obstetrics & Gynaecology, 48(3), 248-254. DOI Scopus40 WoS34 Europe PMC20 |
2008 |
Wodak, A., Ali, R., Sansom, L., & Henry, D. (2008). Ensuring the safety of new medications and devices: are naltrexone implants safe?. Medical Journal of Australia, 188(8), 438-439. DOI Scopus10 WoS8 Europe PMC2 |
2008 |
McKetin, R., Kozel, N., Douglas, J., Ali, R., Vicknasingam, B., Lund, J., & Li, J. (2008). The rise of methamphetamine in southeast and East Asia. Drug and Alcohol Review, 27(3), 220-228. DOI Scopus123 WoS106 Europe PMC78 |
2006 |
O'Brien, S., Mattick, R., White, J., Breen, C., Kimber, J., Ritter, A., & Lintzeris, N. (2006). Maintenance pharmacotherapy for opioid dependence and SF-36 Health status: a comparison with general population norms and other chronic disorders. Addictive Disorders & Their Treatment, 5(4), 155-164. DOI Scopus16 WoS14 |
2006 |
Teesson, M., Ross, J., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2006). One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Dependence, 83(2), 174-180. DOI Scopus119 WoS107 Europe PMC64 |
2006 |
Gowing, L., Ali, R., & White, J. (2006). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal (review). The Cochrane Database of Systematic Reviews, Online(Issue 2. Art. No. CD002022), 1-26. DOI Scopus42 WoS41 Europe PMC14 |
2006 |
Kornor, H., Waal, H., & Ali, R. (2006). Abstinence-orientated buprenorphine replacement therapy for young adults in out-patient counselling. Drug and Alcohol Review, 25(2), 123-130. DOI Scopus10 WoS11 Europe PMC6 |
2006 |
Gowing, L., & Ali, R. (2006). The place of detoxification in treatment of opioid dependence. Current Opinion in Psychiatry, 19(3), 266-270. DOI Scopus23 WoS17 Europe PMC12 |
2006 |
Gowing, L., Ali, R., & White, J. (2006). Opioid antagonists with minimal sedation for opioid withdrawal (review). The Cochrane Database of Systematic Reviews, Online(1AR CD002021DI ARTN CD002021), 2021. DOI Scopus14 WoS4 Europe PMC4 |
2006 |
Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2006). Methadone treatment of injecting opioid users for prevention of HIV infection. Journal of General Internal Medicine (online), 21(2), 193-195. DOI Scopus88 WoS74 Europe PMC53 |
2006 |
Shanahan, M., Doran, C., Digiusto, E., Bell, J., Lintzeris, N., White, J., . . . Gilmour, S. (2006). A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addictive Behaviors, 31(3), 371-387. DOI Scopus21 WoS17 Europe PMC12 |
2006 |
Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2006). Short-term outcomes for the treatment of heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Addictive Disorders and their Treatment, 5(3), 133-143. DOI Scopus25 WoS24 |
2005 |
Amato, L., Davoli, M., Minozzi, S., Ali, R., & Ferri, M. (2005). Methadone at tapered doses for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (3), 34 pages. DOI Scopus70 WoS39 Europe PMC23 |
2005 |
Humeniuk, R., & Ali, R. (2005). The first methadone clinic in Beijing. Drug and Alcohol Review, 24(3), 285-287. DOI Scopus6 WoS5 Europe PMC5 |
2005 |
Reece, A. S. (2005). HIV in injecting drug users in Asian countries: naltrexone implants are set to supersede harm minimisation.. BMJ (Clinical research ed.), 330(7483), 147. DOI |
2005 |
Wodak, A., Ali, R., & Farrell, M. (2005). HIV in injecting drug users in Asian countries - Reply. British Medical Journal, 330(7483), 147. DOI |
2005 |
Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2005). The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review, 24(5), 411-418. DOI Scopus215 WoS196 Europe PMC119 |
2005 |
Darke, S., Ross, J., Teesson, M., Ali, R., Cooke, R., Ritter, A., & Lynskey, M. (2005). Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment, 28(3), 255-263. DOI Scopus86 WoS74 Europe PMC47 |
2005 |
Digiusto, E., Lintzeris, N., Breen, C., Kimber, J., Mattick, R., Bell, J., . . . Saunders, J. (2005). Short-term outcomes of five heroin detoxification methods in the Australian NEPOD project. Addictive Behaviors, 30(3), 443-456. DOI Scopus18 WoS17 Europe PMC13 |
2005 |
Farrell, M., Gowing, L., Marsden, J., Ling, W., & Ali, R. (2005). Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy, 16S(SUPPL. 1), S67-S75. DOI Scopus54 WoS54 |
2005 |
Newcombe, D., Humeniuk, R., & Ali, R. (2005). Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug and Alcohol Review, 24(3), 217-226. DOI Scopus230 WoS191 Europe PMC158 |
2004 |
Ling, W., Farrell, M., & Ali, R. (2004). Cochrane systematic reviews: time for an introduction and appraisal. Drug and Alcohol Dependence, 73(3), 217-218. DOI Scopus6 WoS6 Europe PMC5 |
2004 |
Jittiwutikarn, J., Ali, R., White, J., Bochner, F., Somogyi, A., & Foster, D. (2004). Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre. British Journal of Clinical Pharmacology, 58(5), 536-541. DOI Scopus20 WoS15 Europe PMC10 |
2004 |
Wodak, A., Ali, R., & Farrell, M. (2004). HIV in injecting drug users in Asian countries. British Medical Journal, 329(7468), 697-698. DOI Scopus13 WoS7 Europe PMC7 |
2004 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2004). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online : Update Software), (4), 45 pages. DOI Scopus27 WoS9 Europe PMC10 |
2004 |
Kaya, C. Y., Tugai, Y., Filar, J. A., Agrawal, M. R., Ali, R. L., Gowing, L. R., & Cooke, R. (2004). Heroin users in Australia: population trends. Drug and Alcohol Review, 23(1), 107-116. DOI Scopus14 WoS9 Europe PMC1 |
2004 |
Gowing, L., Ali, R., & White, J. (2004). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (4), CD002025. DOI Scopus34 Europe PMC4 |
2004 |
Gowing, L., Farrell, M., Bornemann, R., & Ali, R. (2004). Substitution treatment of injecting opioid users for prevention of HIV infection.. Cochrane database of systematic reviews (Online), (4), CD004145. DOI Scopus34 Europe PMC10 |
2004 |
Humeniuk, R., & Ali, R. (2004). Amphetamines in Asia: the value of information networks. Drug and Alcohol Review, 23(2), 235-237. DOI Scopus2 |
2004 |
Longo, M. C., Henry-Edwards, S. M., Humeniuk, R. E., Christie, P., & Ali, R. L. (2004). Impact of the heroin 'drought' on patterns of drug use and drug-related harms. Drug and Alcohol Review, 23(2), 143-150. DOI Scopus23 WoS22 Europe PMC13 |
2004 |
Humeniuk, R., Ali, R., & Ling, W. (2004). Substance use and treatment options in Cambodia. Drug and Alcohol Review, 23(3), 365-367. DOI Scopus2 WoS2 Europe PMC2 |
2004 |
Amato, L., Davoli, M., Minozzi, S., Ali, R., & Ferri, M. (2004). Methadone at tapered doses for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (3), CD003409. DOI Europe PMC3 |
2004 |
Humeniuk, R., & Ali, R. (2004). Asia Pacific Column. Announcement of column on capacity building in the Asia Pacific region.. Drug and alcohol review, 23(1), 133-134. DOI |
2003 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2003). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (2), CD002024. DOI Scopus6 Europe PMC8 |
2003 |
Amato, L., Davoli, M., Ferri, M., & Ali, R. (2003). Methadone at tapered doses for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (1), CD003409. DOI Scopus98 Europe PMC3 |
2003 |
Srisurapanont, M., Ali, R., Marsden, J., Sunga, A., Wada, K., & Monteiro, M. (2003). Psychotic symptoms in methamphetamine psychotic in-patients. International Journal of Neuropsychopharmacology, 6(4), 347-352. DOI Scopus145 WoS119 Europe PMC74 |
2003 |
Humeniuk, R., Ali, R., McGregor, C., & Darke, S. (2003). Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia. Addiction, 98(4), 413-418. DOI Scopus42 WoS37 Europe PMC27 |
2003 |
Ali, R., Thomas, P., White, J., McGregor, C., Danz, C., Gowing, L., . . . Athanasos, P. (2003). Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity. Drug and Alcohol Review, 22(4), 425-431. DOI Scopus9 WoS9 Europe PMC6 |
2003 |
Mattick, R., Ali, R., White, J., O'Brien, S., Wolk, S., & Danz, C. (2003). Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction, 98(4), 441-452. DOI Scopus240 WoS209 Europe PMC149 |
2003 |
Doran, C., Shanahan, M., Mattick, R., Ali, R., White, J., & Bell, J. (2003). Buprenorphine versus methadone maintenance: a cost-effectiveness analysis. Drug and Alcohol Dependence, 71(3), 295-302. DOI Scopus97 WoS80 Europe PMC66 |
2002 |
Doverty, M., White, J., Somogyi, A., Bochner, F., Ali, R., & Ling, W. (2002). Reply to Dr. Clark's comment on Doverty et al., hyperalgesic responses in methadone maintenance patients (Pain 2001;90 : 91-96). Pain, 99(3), 609-610. DOI WoS1 |
2002 |
Farrell, M., Marsden, J., Ali, R., & Ling, W. (2002). Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction, 97(7), 771-772. DOI Scopus104 WoS90 Europe PMC65 |
2002 |
Gowing, L., Henry-Edwards, S., Irvine, R., & Ali, R. (2002). The health effects of ecstacy: a literature review. Drug and Alcohol Review, 21(1), 53-63. DOI Scopus127 Europe PMC74 |
2002 |
Gowing, L., Ali, R., & White, J. (2002). Which substitution pharmacotherapy is most effective in treating opioid dependence?. Medical Journal of Australia, 176(10), 493-494. DOI |
2002 |
Ali, R., Awwad, E., Babor, T., Bradley, F., Butau, T., Farrell, M., . . . Vendetti, J. (2002). The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction, 97(9), 1183-1194. DOI Scopus1436 WoS1126 Europe PMC952 |
2002 |
White, J., Danz, C., Kneebone, J., La Vincente, S., Newcombe, D., & Ali, R. (2002). Relationship between LAAM-methadone preference and treatment outcomes. Drug and Alcohol Dependence, 66(3), 295-301. DOI Scopus19 WoS16 Europe PMC10 |
2002 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2002). a₂-Adrenergic agonists in opioid withdrawal. Addiction, 97(1), 49-58. DOI Scopus62 WoS48 Europe PMC46 |
2002 |
McGregor, C., Ali, R., Lokan, R., Christie, P., & Darke, S. (2002). Accidental fatalities among heroin users in South Australia, 1994-1997: Toxicological findings and circumstances of death. Addiction Research and Theory, 10(4), 335-346. DOI Scopus22 WoS14 |
2002 |
McGregor, C., Ali, R., White, J., Thomas, P., & Gowing, L. (2002). A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months. Drug and Alcohol Dependence, 68(1), 5-14. DOI Scopus35 WoS34 Europe PMC24 |
2002 |
Gowing, L., Ali, R., & White, J. (2002). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, (2), CD002025-1-CD002025-22. DOI Scopus21 Europe PMC4 |
2002 |
Gowing, L., Ali, R., & White, J. (2002). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (2), CD002025. DOI Scopus30 Europe PMC8 |
2002 |
Gowing, L., Ali, R., & White, J. (2002). Opioid antagonists with minimal sedation for opioid withdrawal.. Cochrane database of systematic reviews (Online : Update Software), (2), CD002021. DOI Scopus15 Europe PMC3 |
2002 |
Gowing, L. R., Henry-Edwards, S. M., Irvine, R. J., & Ali, R. L. (2002). The health effects of ecstasy: a literature review. DRUG AND ALCOHOL REVIEW, 21(1), 53-63. DOI WoS100 |
2002 |
Gowing, L., Ali, R., & White, J. (2002). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.. Cochrane database of systematic reviews (Online), (2), CD002022. DOI Scopus16 Europe PMC4 |
2002 |
Bammer, G., Hall, W., Hamilton, M., & Ali, R. (2002). Harm minimization in a prohibition context - Australia. Annals of the American Academy of Political and Social Science, 582(JULY), 80-93. DOI Scopus14 WoS11 |
2002 |
Amato, L., Davoli, M., Ferri, M., & Ali, R. (2002). Methadone at tapered doses for the management of opioid withdrawal.. The Cochrane database of systematic reviews, (1), CD003409. DOI Europe PMC1 |
2002 |
Amato, L., Davoli, M., Ferri, M., & Ali, R. (2002). Methadone at tapered doses for the management of opioid withdrawal.. Cochrane Database Syst Rev, (1), CD003409. DOI |
2001 |
McGregor, C., Ali, R., Christie, P., & Darke, S. (2001). Overdose among heroin users: Evaluation of an intervention in South Australia. Addiction Research and Theory, 9(5), 481-501. DOI Scopus17 WoS16 |
2001 |
Gowing, L., Ali, R., & White, J. (2001). Buprenorphine for the management of opioid withdrawal. Praxis, 90(44), 1934. |
2001 |
Mattick, R. P., Ali, R., Auriacombe, M., Davoli, M., Faggiano, F., Farrell, M., . . . Ling, W. (2001). Cochrane drugs and alcohol group: The development of systematic reviews of treatment outcome. Alcohol and Alcoholism, 36(2), 109-111. DOI Scopus3 WoS1 Europe PMC1 |
2001 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2001). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (1), CD002024. DOI Scopus20 Europe PMC17 |
2001 |
Gowing, L., Ali, R., & White, J. (2001). Opioid antagonists under sedation or anaesthesia for opioid withdrawal.. Cochrane database of systematic reviews (Online), (1), CD002022. DOI Scopus11 Europe PMC1 |
2001 |
Doverty, M., White, J., Somogyi, A., Bochner, F., Ali, R., & Ling, W. (2001). Hyperalgesic responses in methadone maintenance patients. Pain, 90(01-Feb), 91-96. DOI Scopus269 WoS210 Europe PMC168 |
2000 |
Gowing, L., Ali, R., & White, J. (2000). Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, (2), 1-2. DOI Scopus15 Europe PMC4 |
2000 |
Gowing, L., Ali, R., & White, J. (2000). The management of opioid withdrawal. Drug and Alcohol Review, 19(3), 309-318. DOI Scopus18 WoS15 |
2000 |
Gowing, L., Ali, R., & White, J. (2000). Systematic review processes and the management of opioid withdrawal. Australian and New Zealand Journal of Public Health, 24(4), 427-431. DOI Scopus5 WoS3 Europe PMC3 |
2000 |
Single, E., Christie, P., & Ali, R. (2000). The impact of cannabis decriminalisation in australia and the united states. Journal of Public Health Policy, 21(2), 157-186. DOI Scopus73 WoS59 Europe PMC20 |
2000 |
Gowing, L., Ali, R., & White, J. (2000). Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. Praxis, 89(44), 1810-1811. |
2000 |
Ali, R., McGregor, C., Christie, P., & Darke, S. (2000). Heroin overdose: Responding to the epidemic. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 34(s1), A1-A2. DOI WoS1 |
2000 |
Christie, P., & Ali, R. (2000). Offences under the Cannabis Expiation Notice scheme in South Australia. Drug and Alcohol Review, 19(3), 251-256. DOI Scopus19 WoS17 |
2000 |
Allsop, S. J., Ali, R. L., & Edmonds, C. A. (2000). A training, authorisation and review process for methadone prescribers. Journal of Maintenance in the Addictions, 1(4), 15-25. DOI Scopus4 |
2000 |
Ali, R. (2000). Special section: Cannabis expiation in South Australia - Introduction. DRUG AND ALCOHOL REVIEW, 19(3), 249. WoS2 |
1999 |
Ali, R., Auriacombe, M., Casas, M., Cottler, L., Farrell, M., Kleiber, D., . . . Ward, P. (1999). Report of the external panel on the evaluation of the Swiss scientific studies of medically prescribed narcotics to drug addicts. Sucht, 45(3), 160-170. Scopus21 |
1999 |
Ali, R. L., & Quigley, A. J. (1999). Accidental drug toxicity associated with methadone maintenance treatment. Medical Journal of Australia, 170(3), 100-101. DOI Scopus5 WoS5 Europe PMC2 |
1999 |
Lenton, S., McDonald, D., Ali, R., & Moore, T. (1999). Laws applying to minor cannabis offences in Australia and their evaluation. International Journal of Drug Policy, 10(4), 299-303. DOI Scopus3 |
1999 |
Vincent, N., Shoobridge, J. A., Ask, A., Allsop, S., & Ali, R. (1999). Characteristics of amphetamine users seeking information, help and treatment in Adelaide, South Australia. Drug and Alcohol Review, 18(1), 63-73. |
1999 |
Vincent, N., Shoobridge, J., Ask, A., Allsop, S., & Ali, R. (1999). Characteristics of amphetamine users seeking information, help and treatment in Adelaide, South Australia.. Drug and Alcohol Review, 18(1), 63-73. DOI Scopus19 WoS17 |
1999 |
Wolff, K., Farrell, M., Marsden, J., Monteiro, M., Ali, R., Welch, S., & Strang, J. (1999). A review of biological indicators of illicit drug use, practical considerations and clinical usefulness.. Addiction, 94(9), 1279-1298. DOI Scopus154 WoS129 Europe PMC84 |
1998 |
Gaughwin, M., Solomon, P., & Ali, R. (1998). Correlates of retention on the South Australian methadone program 1981-91. Australian New Zealand Journal of Public Health, 22(7), 771-776. DOI Scopus11 WoS10 Europe PMC6 |
1998 |
Gowing, L., Ali, R., Christie, P., & White, J. (1998). Therapeutic use of cannabis: clarifying the debate. Drug and Alcohol Review, 17(4), 445-452. DOI WoS2 Europe PMC1 |
1998 |
Vincent, N., Shoobridge, J., Ask, A., Allsop, S., & Ali, R. (1998). Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia. Drug and Alcohol Review, 17(2), 187-195. DOI Scopus29 WoS27 Europe PMC16 |
1998 |
Mcgregor, C., Darke, S., Ali, R., & Christie, P. (1998). Experience of non-fatal overdose among heroin users in Adelaide, Australia: Circumstances and risk perceptions. Addiction, 93(5), 701-711. DOI Scopus183 WoS168 Europe PMC111 |
1997 |
MacDonald, M., Wodak, A. D., Ali, R., Crofts, N., Cunningham, P. H., Dolan, K. A., . . . Kaldor, J. M. (1997). HIV prevalence and risk behaviour in needle exchange attenders: A national study. Medical Journal of Australia, 166(5), 237-240. DOI Scopus64 WoS60 Europe PMC37 |
1997 |
Ali, R. (1997). America's drug war debacle. ADDICTION, 92(12), 1790-1791. |
1996 |
Strang, J., Darke, S., Hall, W., Farrell, M., & Ali, R. (1996). Heroin overdose: the case for take-home naltrexone. British Medical Journal, 312(7044), 1435-1436. DOI Scopus136 WoS122 Europe PMC81 |
1996 |
White, J., Ryan, C., & Ali, R. (1996). Improvements in retention rates and changes in client groups with methadone maintenance streaming.. Drug and Alcohol Review, 15(1), 83-88. DOI Scopus17 WoS14 Europe PMC9 |
1995 |
Gaughwin, M. D., & Ali, R. (1995). HIV infection among injecting drug users in the South Australian methadone program. Medical Journal of Australia, 162(5), 242-244. DOI Scopus6 WoS5 Europe PMC2 |
1994 |
Waddell, R. G., Gaughwin, M., Dodding, J., Ali, R., & Crofts, N. (1994). Hepatitis C and the history of injecting drug use in South Australia [3]. Medical Journal of Australia, 161(4), 286-287. DOI Scopus6 WoS7 Europe PMC1 |
1994 |
GAUGHWIN, M., DODDING, J., & ALI, R. (1994). HEPATITIS-C AND THE HISTORY OF INJECTING DRUG-USE IN SOUTH AUSTRALIA - REPLY. MEDICAL JOURNAL OF AUSTRALIA, 161(4), 286. DOI WoS7 Europe PMC1 |
1994 |
ALI, R. L., & CORMACK, S. M. (1994). In‐patient treatment for the alcohol‐dependent person: a public health perspective. Drug and Alcohol Review, 13(2), 195-202. DOI Scopus4 Europe PMC1 |
1994 |
White, J. M., Dyer, K. R., Ali, R. L., Gaughwin, M. D., & Cormack, S. (1994). Injecting behaviour and risky needle use amongst methadone maintenance clients. Drug and Alcohol Dependence, 34(2), 113-119. DOI Scopus12 WoS11 Europe PMC10 |
1993 |
Gaughwin, M., Kliewer, E., Ali, R., Faulkner, C., Wodak, A., & Anderson, G. (1993). The prescription of methadone for opiate dependence in Australia, 1985-1991. Medical Journal of Australia, 159(2), 107-108. DOI Scopus5 WoS5 Europe PMC3 |
1992 |
Weller, D. P., Litt, J. C. B., Pols, R. G., Ali, R. L., Southgate, D. O., & Harris, R. D. (1992). Drug and alcohol related health problems in primary care - What do GPs think?. Medical Journal of Australia, 156(1), 43-48. DOI Scopus60 WoS60 Europe PMC33 |
1991 |
Gaughwin, M. D., Douglas, R. M., Liew, C., Davies, L., Mylvaganam, A., Treffke, H., . . . Ali, R. (1991). HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS, 5(7), 845-851. DOI Scopus44 WoS29 Europe PMC20 |
1991 |
Gaughwin, M. D., Gowans, E., Ali, R., & Burrell, C. (1991). Bloody needles: The volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS, 5(8), 1025-1027. DOI Scopus47 WoS51 Europe PMC27 |
1990 |
Gaughwin, M. D., Ryan, P., Treffke, H., Lee, M., & Ali, R. (1990). Can I buy a syringe? The availability of needles and syringes to intravenous drug users in Adelaide. Medical Journal of Australia, 153(9), 569. DOI Scopus1 WoS3 |
1990 |
Douglas, R. M., Gaugwhin, M. D., Ali, R. L., Davies, L. M., Mylvaganam, A., & Liew, C. Y. (1990). Risk of transmission of the human immunodeficiency virus in the prison setting. Medical Journal of Australia, 153(7), 434. DOI Europe PMC1 |
1990 |
Gaughwin, M. D., Douglas, R. M., Davies, L., Mylvaganam, A., Liew, C., & Ali, R. (1990). PREVENTING HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AMONG PRISONERS: PRISONERS' AND PRISON OFFICERS' KNOWLEDGE OF HIV AND THEIR ATTITUDES TO OPTIONS FOR PREVENTION. Community Health Studies, 14(1), 61-64. DOI Scopus2 WoS1 |
1989 |
Douglas, R. M., Gaughwin, M. D., Ali, R. L., Davies, L. M., Mylvaganam, A., & Liew, C. Y. (1989). Risk of transmission of the human immunodeficiency virus in the prison setting.. The Medical journal of Australia, 150(12), 722. DOI Scopus11 WoS8 Europe PMC1 |